Search - tctmd.com

Displaying 361 - 380 of 975

Sort: Relevancy | Date

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

Todd Neale

March 25, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Yael L. Maxwell

February 15, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Conference News ISC 2022

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

Todd Neale

February 10, 2022

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Advertisement

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

More Evidence Links Breast Arterial Calcification and CVD Risk

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Guideline-Directed Therapies Underused in Frail HF Patients

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

March 2022 News Roundup

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Fewer Diabetic Complications Seen When NOACs Given for AF

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

February 2022 News Roundup

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content